Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 24, 2014 06:11 ET | Source: EQS Group AG

DGAP-News: Epigenomics AG: Epigenomics' Partner BioChain Successfully Completes Clinical Validation Study for CFDA Approval of Epi proColon(R) in China

DGAP-News: Epigenomics AG / Key word(s): Study/Miscellaneous Epigenomics AG: Epigenomics' Partner BioChain Successfully Completes Clinical Validation Study for CFDA Approval of Epi proColon(R)...
April 24, 2014 05:04 ET | Source: QIAGEN N.V.

QIAGEN Posts 2013 Annual Report on Its Website

VENLO, Netherlands, April 24, 2014 (GLOBE NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) has posted its 2013 Annual Report on its website at...
April 23, 2014 14:58 ET | Source: Keek Inc.

Keek Expands U.S. Presence

TORONTO, ON--(Marketwired - April 23, 2014) - Keek Inc. (TSX VENTURE: KEK) (OTCQX: KEEKF) announces, as part of its continued global expansion the appointment of Alexandra...
April 23, 2014 06:30 ET | Source: Vical Incorporated

Vical Announces News Release and Conference Call Schedule for First Quarter 2014 Financial Results

SAN DIEGO, April 23, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three months ended March 31, 2014, before the...
April 23, 2014 03:00 ET | Source: TagMaster AB

TagMaster launch new UHF reader

Stockholm, Sweden 23 April 2014 TagMaster, the leading producer of advanced RFID products for long range vehicle identification in Traffic Solutions and Rail Solutions, presents a new reader model...
April 22, 2014 07:00 ET | Source: Sunesis Pharmaceuticals, Inc.

Sunesis Announces MD Anderson Sponsored Study of Vosaroxin in AML and High-Risk MDS Poster to be Presented at ASCO 2014

SOUTH SAN FRANCISCO, Calif., April 22, 2014 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that updated data from the ongoing Phase 1b/2 University of Texas MD...
April 22, 2014 02:08 ET | Source: MdxHealth (TM)

MDxHealth Signs Agreement with Galaxy Health Network PPO Providing Increased Access to ConfirmMDx for Prostate Cancer

Agreement Increases Access with Additional 3.5 Million Covered Lives IRVINE, Calif. and HERSTAL, Belgium, April 22, 2014 (GLOBE NEWSWIRE) -- MDxHealth SA (NYSE Euronext: MDXH), a leading molecular...
April 22, 2014 02:00 ET | Source: mdxhealth

MDxHealth Signs Agreement with Galaxy Health Network PPO Providing Increased Access to ConfirmMDx for Prostate Cancer

Agreement Increases Access with Additional 3.5 Million Covered Lives IRVINE, CA, and HERSTAL, BELGIUM -- 8:00 AM, April 22, 2014 MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic...
April 21, 2014 08:00 ET | Source: Donor Egg Bank, USA

Myths About Pregnancy in Your 40s

ROCKVILLE, Md., April 21, 2014 (GLOBE NEWSWIRE) -- Modern motherhood can be difficult to navigate with the conflicting messages that women receive. Celebrities make pregnancy in the 40s look like a...
April 17, 2014 15:34 ET | Source: Genmab A/S

GSK and Genmab Receive FDA Approval for Arzerra® (ofatumumab) as First-Line Treatment in Combination with Chlorambucil for Patients with Chronic Lymphocytic Leukemia (CLL) for Whom Fludarabine-Based Therapy is Considered Inappropriate

Company Announcement Arzerra now approved for use in previously untreated patients for whom fludarabine-based therapy is considered inappropriate Approval based on Phase III data from study...